News
-
Video Interview with Peter Goodhand
At the joint ICPerMed and EP PerMed Conference in Prague, we had the opportunity to discuss with Peter Goodhand (Global Alliance for Genomics and Health) the challenges and progress of integrating genomic research into healthcare worldwide.
-
Video Interview with Irene Norstedt
At the joint ICPerMed and EP PerMed Conference in Prague, we had the opportunity to discuss with Irene Norstedt the European Commission’s strategic approach and sustained efforts to advance personalised medicine since 2010 until today.
-
Deadline extended! Call for Tender on Surveys 2026 – Assessment and Analysis of Genetic Testing
EP PerMed launched its first Call for Tender on Surveys and invites suitable stakeholders to apply. The topic of the tender is the assessment and analysis of genetic testing related to personalised medicine approaches for different countries and health systems. New deadline: 17 March 2026.
-
New Best Practice Example: Genetics-based Personalised Breast Cancer Prevention and Screening
EP PerMed awardes the title of “Best Practice” (BP) in Personalised Medicine to the ‘Genetics-based Personalised Breast Cancer Prevention and Screening’ project. Currently utilised in the private healthcare sectors of several European countries, the service will be implemented in Estonia in 2026 as a national polygenic risk score (PRS)-based personalised breast cancer screening programme.
EP PerMed Fast Track 2026
The EP PerMed Fast Track Programme 2026 offers targeted support to accelerate the validation and adoption of innovative personalised medicine solutions. The programme helps early-stage innovations progress by at least one Technology Readiness Level through dedicated validation studies carried out together with specialised European validation centres.
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.